期刊文献+

卵巢癌患者生活质量的研究 被引量:14

Quality of Life for Patients with Ovarian Cancer
下载PDF
导出
摘要 尽管卵巢癌的诊断和治疗技术不断发展,其病死率仍居妇科恶性肿瘤首位。在疾病每一阶段(手术、化疗、随访、复发及其后的治疗、肠梗阻以及临终阶段)生活质量始终是应考虑的最重要因素之一。近年来,大量研究对卵巢癌患者的生活质量进行评估。不同的化疗药物、化疗途径以及化疗时机对卵巢癌患者的生活质量有不同的影响。选择不同的治疗方案以及治疗效果的不同对患者生活质量的影响也有差别。治疗后出现的并发症及晚期卵巢癌患者的症状都会影响患者的生活质量。其他如情感问题,包括心理情绪问题、婚姻、家庭社会支持等也会导致生活质量的改变。 Despite advances in diagnostic techniques and therapy ,ovarian cancer is the most malignant cancer in women, and the first leading cause of cancer related death of the gynecologic malignancy. In each phase of the illness (surgery and chemotherapy,follow-up,relapse and sequential therapy,bowel obstruction and end of life),quality of life (QOL) is one of the most important considerations. In the recent years ,the assessments of the quality of life in patients with ovarian cancer have increased. Different agents for the chemotherapy,intraperitoneal therapy,the timing for the chemotherapy,different therapy,and the therapeutic effect are all the influencing factors for the quality of life in the patients with ovarian cancer. The other factors such as psychological and emotional problems,family and social assistance,sexual issues and menopausal syndrome will also affect quality of life.
作者 饶阳 曲芃芃
出处 《国际妇产科学杂志》 CAS 2014年第3期244-246,289,共4页 Journal of International Obstetrics and Gynecology
关键词 卵巢肿瘤 化学疗法 肿瘤 局部灌注 生活质量 肿瘤治疗方案 Ovarian neoplasms Chemotherapy,cancer,regional perfusion Quality of life Antineoplastic protocols
  • 相关文献

参考文献25

  • 1Siegel R,Naishadham Di Iemal A.Cancer statistics,2012 [J].CA Cancer J Clin,2012,62(1):10-29. 被引量:1
  • 2Mercado C,Zingmond D,Karlan B,et al.Quality of care in advanced ovarian cancer:the importance of provider specialty(1).Gynecol Oncol,2010,117(1):18-22. 被引量:1
  • 3Chase DM,Watanabe T,Monk BJ.Assessment and significance of quality of life in women with gynecologic cancer [J].Future Oncol,2010,6(8):1279-1287. 被引量:1
  • 4Smith AB,Wright P,Selby PJ,et al.A Rasch and factor analysis of the Functional Assessment of Cancer Therapy-General(FACT-G)[J].Health Qual Life Outcomes,2007,5:19. 被引量:1
  • 5Scott NW,Fayers PM,Aronson NK,et al.The use of differential item functioning analyses to identify cultural differences in responses to the EORTC QLQ-C30[J].Qual Life Res,2007,16(1):115-129. 被引量:1
  • 6Greimel ER,Bjelic-Radisic V.Pfisterer J,et al.Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatinlpaclitaxel versus carboplatinlpaclitaxel [J].J Clin Oncol,2006,24(4):579-586. 被引量:1
  • 7Mori T,Hosokawa K,Kinoshita Y,et al.A pilot study of docetaxelcarboplatin versus paclitaxel-carboplatin in Japanese patients with epithelial ovarian cancer[J].Int J Clin Oncol,2007,12(3):205-211. 被引量:1
  • 8Pujade-Lauraine E,Wagner U,Aavall-Lundqvist E,et al.Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse[J].J Clin Oncol,2010,28(20):3323-3329. 被引量:1
  • 9von Gruenigen VE,Huang HQ,Gil KM,et al.The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy:a gynecologic oncology group study[J].Gynecol Oncol,2012,124(3):379-382. 被引量:1
  • 10Chase DM,Wenzel L.Health-related quality of life in ovarian cancer patients and its impact on clinical management [J].Expert Rev Pharmacoecon Outcomes Res,2011,11(4):421-431. 被引量:1

同被引文献140

引证文献14

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部